Emily A. King
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Emily A. King has a total of 113 co-authors. Here are the top co-authors by number of shared publications:
- Belinda J. McClaren
Murdoch Children’s Research Institute, Melbourne, Australia
4 shared publications - Ainsley Janelle Newson
The University of Sydney
3 shared publications - Alison Dalton Archibald
Department of Paediatrics, The University of Melbourne, Parkville, Australia
2 shared publications - Bruce Bennetts
Sydney Genome Diagnostics, Western Sydney Genetics Program, Sydney Children’s Hospitals Network, Westmead, NSW 2145, Australia
2 shared publications - Edwin Philip Kirk
Genomics Laboratory New South Wales Health Pathology Randwick New South Wales Australia
2 shared publications - Evanthia Olympia Madelli
Australian Genomics, Parkville, Australia
2 shared publications
Latest Publications
- Top Cited Papers
- 21 November 2024
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 391 (20) , 1877-1889
Nationwide, Couple-Based Genetic Carrier Screening
Genomic sequencing technology allows for identification of reproductive couples with an increased chance, as compared with that in the general population, of having a child with an autosomal recessive or X-linked genetic condition. We investigated the feasibility, acceptability, and outcomes of a nationwide, couple-based genetic carrier screening program in Australia as part of the Mackenzie's Mission project. Health care providers offered screening to persons before pregnancy or early in pregnancy. The results obtained from testing at least 1281 genes were provided to the reproductive couples. We aimed to ascertain the psychosocial effects on participants, the acceptability of screening to all participants, and the reproductive choices of persons identified as having an increased chance of having a child with a condition for which we screened. Among 10,038 reproductive couples enrolled in the study, 9107 (90.7%) completed screening, and 175 (1.9%) were newly identified as having an increased chance of having a child with a genetic condition for which we screened. These conditions involved pathogenic variants in 90 different genes; 74.3% of the conditions were autosomal recessive. Three months after receiving the results, 76.6% of the couples with a newly identified increased chance had used or planned to use reproductive interventions to avoid having an affected child. Those newly identified as having an increased chance had greater anxiety than those with a low chance. The median level of decisional regret was low in all result groups, and 98.9% of participants perceived screening to be acceptable. Couple-based reproductive genetic carrier screening was largely acceptable to participants and was used to inform reproductive decision making. The delivery of screening to a diverse and geographically dispersed population was feasible. (Funded by the Medical Research Future Fund of the Australian government; ClinicalTrials.gov number, NCT04157595.).
- 21 November 2024
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 391 (20) , 1877-1889
Top Cited PapersNationwide, Couple-Based Genetic Carrier Screening
Genomic sequencing technology allows for identification of reproductive couples with an increased chance, as compared with that in the general population, of having a child with an autosomal recessive or X-linked genetic condition. We investigated the feasibility, acceptability, and outcomes of a nationwide, couple-based genetic carrier screening program in Australia as part of the Mackenzie's Mission project. Health care providers offered screening to persons before pregnancy or early in pregnancy. The results obtained from testing at least 1281 genes were provided to the reproductive couples. We aimed to ascertain the psychosocial effects on participants, the acceptability of screening to all participants, and the reproductive choices of persons identified as having an increased chance of having a child with a condition for which we screened. Among 10,038 reproductive couples enrolled in the study, 9107 (90.7%) completed screening, and 175 (1.9%) were newly identified as having an increased chance of having a child with a genetic condition for which we screened. These conditions involved pathogenic variants in 90 different genes; 74.3% of the conditions were autosomal recessive. Three months after receiving the results, 76.6% of the couples with a newly identified increased chance had used or planned to use reproductive interventions to avoid having an affected child. Those newly identified as having an increased chance had greater anxiety than those with a low chance. The median level of decisional regret was low in all result groups, and 98.9% of participants perceived screening to be acceptable. Couple-based reproductive genetic carrier screening was largely acceptable to participants and was used to inform reproductive decision making. The delivery of screening to a diverse and geographically dispersed population was feasible. (Funded by the Medical Research Future Fund of the Australian government; ClinicalTrials.gov number, NCT04157595.).
- Open Access
- 28 October 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (11) , 1781
The Australian Reproductive Genetic Carrier Screening Project (Mackenzie’s Mission): Design and Implementation
Reproductive genetic carrier screening (RGCS) provides people with information about their chance of having children with autosomal recessive or X-linked genetic conditions, enabling informed reproductive decision-making. RGCS is recommended to be offered to all couples during preconception or in early pregnancy. However, cost and a lack of awareness may prevent access. To address this, the Australian Government funded Mackenzie’s Mission—the Australian Reproductive Genetic Carrier Screening Project. Mackenzie’s Mission aims to assess the acceptability and feasibility of an easily accessible RGCS program, provided free of charge to the participant. In study Phase 1, implementation needs were mapped, and key study elements were developed. In Phase 2, RGCS is being offered by healthcare providers educated by the study team. Reproductive couples who provide consent are screened for over 1200 genes associated with >750 serious, childhood-onset genetic conditions. Those with an increased chance result are provided comprehensive genetic counseling support. Reproductive couples, recruiting healthcare providers, and study team members are also invited to complete surveys and/or interviews. In Phase 3, a mixed-methods analysis will be undertaken to assess the program outcomes, psychosocial implications and implementation considerations alongside an ongoing bioethical analysis and a health economic evaluation. Findings will inform the implementation of an ethically robust RGCS program.
- 28 October 2022
- Published by MDPI AG in Journal of Personalized Medicine
- Vol. 12 (11) , 1781
Open AccessThe Australian Reproductive Genetic Carrier Screening Project (Mackenzie’s Mission): Design and Implementation
Reproductive genetic carrier screening (RGCS) provides people with information about their chance of having children with autosomal recessive or X-linked genetic conditions, enabling informed reproductive decision-making. RGCS is recommended to be offered to all couples during preconception or in early pregnancy. However, cost and a lack of awareness may prevent access. To address this, the Australian Government funded Mackenzie’s Mission—the Australian Reproductive Genetic Carrier Screening Project. Mackenzie’s Mission aims to assess the acceptability and feasibility of an easily accessible RGCS program, provided free of charge to the participant. In study Phase 1, implementation needs were mapped, and key study elements were developed. In Phase 2, RGCS is being offered by healthcare providers educated by the study team. Reproductive couples who provide consent are screened for over 1200 genes associated with >750 serious, childhood-onset genetic conditions. Those with an increased chance result are provided comprehensive genetic counseling support. Reproductive couples, recruiting healthcare providers, and study team members are also invited to complete surveys and/or interviews. In Phase 3, a mixed-methods analysis will be undertaken to assess the program outcomes, psychosocial implications and implementation considerations alongside an ongoing bioethical analysis and a health economic evaluation. Findings will inform the implementation of an ethically robust RGCS program.
- 1 November 2021
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 30 (2) , 194-202
Development and use of the Australian reproductive genetic carrier screening decision aid
Reproductive genetic carrier screening (RGCS) may be offered to all individuals and couples, regardless of family history or ethnicity. “Mackenzie’s Mission” (MM) is an Australian RGCS pilot study, evaluating the offer of couple-based screening for ~1300 genes associated with around 750 autosomal and X-linked recessive childhood-onset conditions. Each member of the couple makes an individual decision about RGCS and provides consent. We developed a decision aid (RGCS-DA) to support informed decision-making in MM, suitable for couples who were either non-pregnant or in early pregnancy. A Delphi approach invited experts to review values statements related to various concepts of RGCS. Three review rounds were completed, seeking consensus for relevance and clarity of statements, incorporating recommended modifications in subsequent iterations. The final RGCS-DA contains 14 statements that achieved Delphi consensus plus the attitude scale of the measure of informed choice. This was then evaluated in cognitive talk aloud interviews with potential users to assess face and content validity. Minimal wording changes were required at this stage. After this process, the RGCS-DA was piloted with 15 couples participating in MM who were then interviewed about their decision-making. The RGCS-DA prompted discussion within couples and facilitated in depth consideration of screening. There was reassurance when values aligned and a sense of shared decision-making within the couple. This RGCS-DA may become a very useful tool in supporting couples’ decision making and contribute to RGCS being feasible for scaled-up implementation.
- 1 November 2021
- Published by Springer Nature in European Journal of Human Genetics
- Vol. 30 (2) , 194-202
Development and use of the Australian reproductive genetic carrier screening decision aid
Reproductive genetic carrier screening (RGCS) may be offered to all individuals and couples, regardless of family history or ethnicity. “Mackenzie’s Mission” (MM) is an Australian RGCS pilot study, evaluating the offer of couple-based screening for ~1300 genes associated with around 750 autosomal and X-linked recessive childhood-onset conditions. Each member of the couple makes an individual decision about RGCS and provides consent. We developed a decision aid (RGCS-DA) to support informed decision-making in MM, suitable for couples who were either non-pregnant or in early pregnancy. A Delphi approach invited experts to review values statements related to various concepts of RGCS. Three review rounds were completed, seeking consensus for relevance and clarity of statements, incorporating recommended modifications in subsequent iterations. The final RGCS-DA contains 14 statements that achieved Delphi consensus plus the attitude scale of the measure of informed choice. This was then evaluated in cognitive talk aloud interviews with potential users to assess face and content validity. Minimal wording changes were required at this stage. After this process, the RGCS-DA was piloted with 15 couples participating in MM who were then interviewed about their decision-making. The RGCS-DA prompted discussion within couples and facilitated in depth consideration of screening. There was reassurance when values aligned and a sense of shared decision-making within the couple. This RGCS-DA may become a very useful tool in supporting couples’ decision making and contribute to RGCS being feasible for scaled-up implementation.
- Open Access
- 28 April 2021
- Published by BMJ
- Vol. 12 (Suppl 1) , A19-A20
P13 Clinical features significantly associated with higher risk of catheter-related blood stream infection (CRBSI) in children on long-term parenteral nutrition (PN)
Objectives and study Catheter-related bloodstream infection (CRBSI) is a common and serious complication of parenteral nutrition (PN). We aimed to determine incidence and risk factors for CRBSI in children receiving long-term home PN at home for Intestinal Failure (IF). Methods Diagnosis of CRBSI was based on clinical manifestations of infection such as fever, rigors, and/or hypotension together with positive blood culture obtained via the central venous catheter (CVC) and absence of other potential sources of infection. The incidence of CRBSI was measured as number of catheter-related episodes per 1000 catheter days. Data regarding potential risk factors for CRBSI such as young age Results The study group included 58 children (26 male, aged 7.2±4.6 years). Aetiology of IF included gastro-intestinal motility disorder (26/58), short bowel syndrome (SBS) (21/58) and enteropathy (Ent) (11/58). There were a total of 58414 catheter observation-days. Thirty-one of 58 (53.4%) children (15 M, aged 5.8±4.3 years) were diagnosed with 108 CRBSIs, a rate of 1.85/1000 catheter days. The median (range) number of CRBSI episodes per patient was 1 (0–14). The median days receiving PN was 1391 (range 75–1565), the median weekly PN infusion frequency was 7 days (range 1–7) and the median weekly lipid infusion was 3 days (range 0–5). CRBSI patients had significantly more PN infusions/week (7, range 2–7 vs 7, range 1–7; P Conclusion Almost half of the children receiving home PN for IF do not develop CRBSI. Children with motility disorder are at highest risk of CRBSI. Moreover, the presence of enterocutaneous stoma, double-lumen CVC and age <5 years significantly increase the risk of developing CRBSI. These risk factors should be considered in the management of home PN in children with IF.
- 28 April 2021
- Published by BMJ
- Vol. 12 (Suppl 1) , A19-A20
Open AccessP13 Clinical features significantly associated with higher risk of catheter-related blood stream infection (CRBSI) in children on long-term parenteral nutrition (PN)
Objectives and study Catheter-related bloodstream infection (CRBSI) is a common and serious complication of parenteral nutrition (PN). We aimed to determine incidence and risk factors for CRBSI in children receiving long-term home PN at home for Intestinal Failure (IF). Methods Diagnosis of CRBSI was based on clinical manifestations of infection such as fever, rigors, and/or hypotension together with positive blood culture obtained via the central venous catheter (CVC) and absence of other potential sources of infection. The incidence of CRBSI was measured as number of catheter-related episodes per 1000 catheter days. Data regarding potential risk factors for CRBSI such as young age Results The study group included 58 children (26 male, aged 7.2±4.6 years). Aetiology of IF included gastro-intestinal motility disorder (26/58), short bowel syndrome (SBS) (21/58) and enteropathy (Ent) (11/58). There were a total of 58414 catheter observation-days. Thirty-one of 58 (53.4%) children (15 M, aged 5.8±4.3 years) were diagnosed with 108 CRBSIs, a rate of 1.85/1000 catheter days. The median (range) number of CRBSI episodes per patient was 1 (0–14). The median days receiving PN was 1391 (range 75–1565), the median weekly PN infusion frequency was 7 days (range 1–7) and the median weekly lipid infusion was 3 days (range 0–5). CRBSI patients had significantly more PN infusions/week (7, range 2–7 vs 7, range 1–7; P Conclusion Almost half of the children receiving home PN for IF do not develop CRBSI. Children with motility disorder are at highest risk of CRBSI. Moreover, the presence of enterocutaneous stoma, double-lumen CVC and age <5 years significantly increase the risk of developing CRBSI. These risk factors should be considered in the management of home PN in children with IF.
- Open Access
- 3 March 2020
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 11, 59
Development of an Evidence-Based, Theory-Informed National Survey of Physician Preparedness for Genomic Medicine and Preferences for Genomics Continuing Education
Despite some early implementation of genomic medicine globally, there is a lack of rigorous, large-scale assessments of medical specialists' current practice and continuing education needs. As a first step to addressing this gap, we describe the development of a robust, expert-reviewed, survey using a mixed-methods sequential study design. We conducted semi-structured qualitative interviews with 32 education providers and 86 non-genetic medical specialists about current genomic medicine practice and need for continuing education. Key concepts were identified and used as an initial framework for the survey. These were: personal characteristics (medical specialty, years of practice); current practice of genomics in clinical and research settings; perception of how proximal genomic medicine is to practice; perception of preparedness (competence and confidence); and, preferences for future roles and models of care in genomic medicine and for continuing education. Potential survey questions that related to at least one of these concepts were identified from the literature or were created if no suitable question existed. Using a modified, reactive Delphi approach, questions were reviewed by a panel of 22 experts. Experts were selected purposefully representing four areas of expertise: non-genetic medical specialties; clinical genetics; genetic/genomic education and evaluation; and implementation science. Three Delphi rounds assessed relevance, clarity and importance of each question. The questions were also mapped to the behaviour change wheel theoretical framework which encompasses capability, opportunity and motivation (COM-B). The survey (included as supplementary material) was then tested with a small group of non-genetic medical specialists and feedback was written or verbal in ‘talk-aloud', cognitive interviews. The final survey was then piloted with a further 29 specialists. We describe the methodology to create a robust, data- and theory-informed survey. The final survey captures not only levels of experience, practice of genomics and preferences for education but also the challenges around engaging with education. Survey data will provide evidence for education providers to inform development of education which meets learner needs and contributes to a medical workforce that is literate in genomics and more confident to competently practice genomic medicine.
- 3 March 2020
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 11, 59
Open AccessDevelopment of an Evidence-Based, Theory-Informed National Survey of Physician Preparedness for Genomic Medicine and Preferences for Genomics Continuing Education
Despite some early implementation of genomic medicine globally, there is a lack of rigorous, large-scale assessments of medical specialists' current practice and continuing education needs. As a first step to addressing this gap, we describe the development of a robust, expert-reviewed, survey using a mixed-methods sequential study design. We conducted semi-structured qualitative interviews with 32 education providers and 86 non-genetic medical specialists about current genomic medicine practice and need for continuing education. Key concepts were identified and used as an initial framework for the survey. These were: personal characteristics (medical specialty, years of practice); current practice of genomics in clinical and research settings; perception of how proximal genomic medicine is to practice; perception of preparedness (competence and confidence); and, preferences for future roles and models of care in genomic medicine and for continuing education. Potential survey questions that related to at least one of these concepts were identified from the literature or were created if no suitable question existed. Using a modified, reactive Delphi approach, questions were reviewed by a panel of 22 experts. Experts were selected purposefully representing four areas of expertise: non-genetic medical specialties; clinical genetics; genetic/genomic education and evaluation; and implementation science. Three Delphi rounds assessed relevance, clarity and importance of each question. The questions were also mapped to the behaviour change wheel theoretical framework which encompasses capability, opportunity and motivation (COM-B). The survey (included as supplementary material) was then tested with a small group of non-genetic medical specialists and feedback was written or verbal in ‘talk-aloud', cognitive interviews. The final survey was then piloted with a further 29 specialists. We describe the methodology to create a robust, data- and theory-informed survey. The final survey captures not only levels of experience, practice of genomics and preferences for education but also the challenges around engaging with education. Survey data will provide evidence for education providers to inform development of education which meets learner needs and contributes to a medical workforce that is literate in genomics and more confident to competently practice genomic medicine.